Denali Therapeutics Inc. is a biotechnology company focused on discovering and developing therapeutic interventions for neurodegenerative diseases. The primary aim of the company is to combat disorder... Denali Therapeutics Inc. is a biotechnology company focused on discovering and developing therapeutic interventions for neurodegenerative diseases. The primary aim of the company is to combat disorders linked to degeneration of the nervous system, such as Alzheimer's, Parkinson's, and ALS, by targeting and addressing underlying mechanisms of these diseases. Denali Therapeutics employs a unique engineering-driven approach, leveraging its deep understanding of biological pathways to create therapies that can cross the blood-brain barrier, an essential obstacle in the treatment of central nervous system diseases. Based in South San Francisco, California, Denali Therapeutics is at the forefront of the biotech industry, collaborating with research institutions and other pharmaceutical companies to advance its pipeline of potential treatments. Its work is pivotal in addressing unmet medical needs related to neurodegeneration, positioning the company as an important player in the pursuit of innovative healthcare solutions aimed at improving the quality of life for affected patients.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Energy Management data not yet covered for Denali Therapeutics

We have not yet reviewed Denali Therapeutics's disclosures for Energy Management data.

If this data is relevant to your work, you can submit a data coverage request and our team will investigate the company's disclosures and capture the data if available.

Would you like us to review Denali Therapeutics's data?

Create a free Tracenable account to signal interest in having our team review data for Denali Therapeutics.

Legal Center Contact Us